Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero

被引:127
作者
Waalkes, MP
Liu, J
Chen, H
Xie, YX
Achanzar, WE
Zhou, YS
Cheng, ML
Diwan, BA
机构
[1] NIEHS, Inorgan Carcinogenesis Sect, Comparat Carcinogenesis Lab, NCI, Res Triangle Pk, NC 27709 USA
[2] SW Prefecture Endem Prevent Stn, Guizhou, Peoples R China
[3] Guiyang Med Coll, Guizhou, Peoples R China
[4] NCI, Basic Res Program, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 06期
关键词
D O I
10.1093/jnci/djh070
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Exposure of pregnant mice to inorganic arsenic induces a spectrum of tumors, including hepatocellular carcinoma (HCC), in their adult offspring similar to that induced by exposing adult mice to estrogenic compounds. To investigate whether arsenic exposure in utero causes altered estrogen signaling, we examined expression of estrogen receptor-alpha (ER-alpha), cyclin D1 (an estrogen-responsive hepatic oncogene), and several cytochrome P450 genes (with sexually dimorphic liver expression patterns) in livers from adult male mice with in utero arsenic-induced HCC. Methods: Quantitative real-time reverse transcription-polymerase chain reaction was used to evaluate gene expression in livers of adult male mice that had (i.e., exposed mice; n = 8) or had not (i.e., control mice; n = 5) been exposed to arsenic in utero. DNA methylation status of portions of the ER-alpha and cyclin D1 gene promoters in liver tissue was measured using methylation-specific polymerase chain reaction. Statistical tests were two-sided. Results: ER-alpha mRNA levels were 3.1-fold (95% confidence interval [CI] = 2.0-fold to 4.3-fold) higher in livers of exposed mice than in those of control mice, and cyclin D1 levels were 3.0-fold (95% CI = 1.7-fold to 4.3-fold) higher. Exposed mice showed a feminized expression pattern of several cytochrome P450 genes, expressing the female-dominant CYP2A4 (P = .017 versus control) and CYP2B9 (P < .001) genes at 8.7 and 10.5 times, respectively, the level in control mice and expressing the male-dominant CYP7B1 at approximately one-fourth the level in control mice (P = .0012). Exposed mice exhibited reduced (by approximately 90%) methylation of the ER-alpha gene promoter in liver DNA as compared with control mice; the cyclin D1 gene promoter was not methylated in either exposed or control mice. Conclusion: Altered estrogen signaling may play a role in induction of HCC by arsenic exposure in utero. Specifically, overexpression of ER-alpha, potentially through promoter region hypomethylation, in livers of such mice may be linked to the hepatocarcinogenicity of arsenic.
引用
收藏
页码:466 / 474
页数:9
相关论文
共 62 条
  • [1] Critical windows of exposure for children's health: Cancer in human epidemiological studies and neoplasms in experimental animal models
    Anderson, LM
    Diwan, BA
    Fear, NT
    Roman, E
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 : 573 - 594
  • [2] Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
    Archey, WB
    McEachern, KA
    Robson, M
    Offit, K
    Vaziri, SAJ
    Casey, G
    Borg, Å
    Arrick, BA
    [J]. ONCOGENE, 2002, 21 (46) : 7034 - 7041
  • [3] DNA METHYLATION IN FOLATE-DEFICIENCY - USE OF CPG METHYLASE
    BALAGHI, M
    WAGNER, C
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (03) : 1184 - 1190
  • [4] DIETHYLSTILBESTROL INDUCES NEOPLASTIC TRANSFORMATION WITHOUT MEASURABLE GENE MUTATION AT 2 LOCI
    BARRETT, JC
    WONG, A
    MCLACHLAN, JA
    [J]. SCIENCE, 1981, 212 (4501) : 1402 - 1404
  • [5] Genetic toxicology of a paradoxical human carcinogen, arsenic: a review
    Basu, A
    Mahata, J
    Gupta, S
    Giri, AK
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2001, 488 (02) : 171 - 194
  • [6] ARSENIC INGESTION AND INTERNAL CANCERS - A REVIEW
    BATES, MN
    SMITH, AH
    HOPENHAYNRICH, C
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 135 (05) : 462 - 476
  • [7] Pathology related to chronic arsenic exposure
    Centeno, JA
    Mullick, FG
    Martinez, L
    Page, NP
    Gibb, H
    Longfellow, D
    Thompson, C
    Ladich, ER
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2002, 110 : 883 - 886
  • [8] Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture
    Chattopadhyay, S
    Bhaumik, S
    Chaudhury, AN
    Das Gupta, S
    [J]. TOXICOLOGY LETTERS, 2002, 128 (1-3) : 73 - 84
  • [9] Epidemiological characteristics and risk factors of hepatocellular carcinoma
    Chen, CJ
    Yu, MW
    Liaw, YF
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 12 (9-10) : S294 - S308
  • [10] Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation
    Chen, H
    Liu, J
    Zhao, CQ
    Diwan, BA
    Merrick, BA
    Waalkes, MP
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 175 (03) : 260 - 268